Cost-effectiveness watchdog NICE has recommended routine NHS use of two new therapies for women with advanced breast cancer – Gilead's Trodelvy and Novartis' Piqray – in England.

Following entry into a commercial agreement with Bayer, NHS England is the first healthcare ... for a diagnostic test for HER2-ultralow breast cancer, now on the label of AstraZeneca and Daiichi ...

Bishal Gyawali, MD, PhD, and Sharon Batt, PhD, explore why overall survival continues to be the most patient-centric marker of clinical benefit.

It usually develops beneath the skin. While an armpit lump can be a symptom of breast cancer, it is not usually the first sign of breast cancer. Instead, the most common symptom of breast cancer is a ...

A new site has been opened for breast cancer screening, available to women in the West Devon area ... “Patients will still be able to attend the mobile unit or University Hospitals Plymouth NHS Trust ...

28, 2025 — The test can differentiate between various grades of cancer, helping men avoid unnecessary ... Routine Brain MRI Screening in Asymptomatic Late Stage Breast Cancer Patients Jan.

The NHS has issued a warning about the signs of a deadly cancer that can manifest when you eat, as new data reveals the UK is battling significantly higher rates of this disease than most of Europe.

The NHS Standard Contract is mandated by NHS England for use by commissioners for all contracts for healthcare services other than primary care, and NHS England is now consulting on changes to the ...

Hopefully scientists are working on treatments to battle breast cancer that don't have hair loss ... isn't standard practice across the NHS. This needs to change. And medical teams must ensure ...

Shocking new figures shows the UK has the second-worst rate of this killer cancer compared to the rest of Europe By Fiona Callingham, Health Reporter specialising in medical studies, symptoms of ...

The guidance on developing the joint forward plan supports integrated care boards, their partner NHS trusts and foundation trusts to continue to develop their joint forward plans with system partners.

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.